rejigg

Pharmaceuticals & Biotech Businesses for Sale

The compliance infrastructure, multi-year customer contracts, and switching costs built into regulated workflows are what make the best pharma and biotech businesses so hard for competitors to replicate.

Browse Listings

2

New This Month

13

Active Listings

$3.3M

Median Asking Price

Browse listings

Featured Pharmaceuticals & Biotech Businesses

Showing 13 of 13 listings

Mushroom Wellness Products Business

Specializes in artisan-crafted mushroom extracts and holistic products like tinctures, essences, gummies, syrups, and coffee blends made from ethically and sustainably sourced US-grown mushrooms for health-conscious individuals, wellness practitioners, and medical professionals.
Price$1.2M
Revenue$2.3M
SDE$499.3K

Vitamins / Supplements Business

Develops microemulsion-based oral spray vitamins and supplements with higher absorption using vegan, non-gmo ingredients, sold direct-to-consumer and wholesale with subscription options
Price$307K
Revenue$221.9K
SDE$65K

Prescription Drug and Medical Diagnostic Wholesaler

Specializes in distributing diagnostic drugs and prescription medications, offering products like point-of-care testing and disposables, with strategic partnerships facilitating efficient and affordable healthcare solutions for healthcare customers including pharmacies, government entities, and urgent care centers.
Price$7M
Revenue$6M
EBITDA$1.5M

Pain Management Medical Device Company

Manufactures and distributes non-narcotic, non-surgical pain management devices for home and clinical use, with a focus on opioid-free alternatives and streamlined recovery solutions.
Price$20M
Revenue$4M
SDE$1.9M

Online Health and Wellness Store

Specializes in high-quality vitamins, nutritional supplements, and natural remedies to enhance health aspects such as immune support, digestive function, cardiovascular health, and beauty care for both B2C and small B2B customers, with a significant international presence and recurring revenue from product subscriptions.
Price-
Revenue$900K
EBITDA-$20K

Chemical Supplier

Supplies high-quality biochemical reagents and small molecule drugs to researchers in academic, biotechnology, biomedical, and pharmaceutical sectors.
Price-
Revenue$3M
SDE$1M

Digital Creative Agency for Biotech Industry

Develops science-based strategies, high-value video productions, and innovative initiatives for pharmaceutical and biotechnology companies to differentiate and communicate their products to healthcare professionals and consumers.
Price$300K
Revenue$209.4K
EBITDA$113.9K

Wellness Products Retailer

Specializes in berberine and liquid collagen supplements with unique formulations for weight management, anti-aging, and overall wellness targeting health-conscious adults.
Price$2.3M
Revenue$687.2K
EBITDA$212.8K

Biotechnology Research & Assay Development Laboratory

Develops and validates custom immunoassay kits, antibodies, proteins, and biomarker testing services, specializing in glp-compliant luminex and elisa multiplex cytokine analysis for drug discovery and pre-clinical infectious disease research
Price$4.3M
Revenue$2.4M
SDE$1.2M

Research Diagnostics and Biotechnology Company

Provides research products and CRO services for anti-cancer and antibiotic drug discovery, including enzymes, assay kits, antibodies, screening tools, and consulting, targeting researchers and scientists globally in big pharma and academia.
Price-
Revenue$246.1K
SDE$229.6K

Medical Research Company

Provides integrated research and clinical trial services for pharmaceutical companies, leveraging 25 years of industry experience.
Price-
Revenue$790.4K
EBITDA-$11.7K

Life Sciences Technology Business

Provides human-derived tissue solutions to advance pre-clinical drug development, focusing on metabolic diseases, stem cells, and cancer treatments, with revenue from product sales and recurring service-based technology offerings.
Price$10M
Revenue$2.1M
SDE$300K

Lab Testing and Consulting for Food and Drug Industry

Provides analytical testing, sampling, and consulting services to the cannabis, hemp, food, and pharmaceutical industries, with revenue generated through contracts with cannabis businesses, grocery stores, and pharmaceutical companies.
Price-
Revenue$1.3M
EBITDA$225K
Explore with filters

Search, filter, and find your perfect opportunity

Due diligence

What to Look For

Practical guidance from hundreds of real acquisition conversations.

Subscription Revenue Share

  • Ask what percentage of revenue comes from subscriptions or annual contracts that renew automatically versus one-time project work.
  • High recurring revenue changes the risk profile from day one and tends to support stronger financing terms.
  • A business where 60 percent or more of revenue is contracted and predictable is a very different starting point than a project-driven one.

Customer Switching Costs

  • In regulated industries, switching away from a compliance or traceability platform requires a full revalidation process that can cost hundreds of thousands of dollars and months of disruption.
  • Ask how embedded the product is in each customer's actual operations, not just how long they've been a customer.
  • Customers who would need months to revalidate before switching are the kind of retention story that holds through ownership changes.

Customer Tenure and Concentration

  • Ask for a customer list with tenure dates, even if names are anonymized early in the process.
  • Customers on the platform for five or more years without churning are a strong signal that the product genuinely delivers what it promises.
  • Check whether any single customer represents more than 20 to 25 percent of revenue, and spend time understanding that relationship if they do.

Compliance Documentation

  • Ask to see FDA records, validation documentation, and compliance certifications, and check that they're organized and current.
  • Missing or disorganized compliance records can slow the process down and create questions that are hard to answer quickly.
  • A seller with clean, well-maintained compliance files is signaling that the business has been run with real discipline.

Expansion Potential

  • Some of the best businesses in this space have proven their platform in one vertical and have clear, untapped potential in adjacent ones like animal health, food safety, or medical devices.
  • Ask where the product has already expanded and where it hasn't yet, which tells you a lot about the growth opportunity you'd be acquiring.
  • A proven platform in one regulated market with a natural path into a second is a meaningful strategic advantage.

Valuation

What Should You Expect to Pay?

3x-6x

SDE

Founder-dependent with some recurring revenue

6x-12x

EBITDA

With team running independently and high recurring revenue from long-tenure customers

The spread is driven by how much revenue is truly recurring, how embedded the product is in customer operations, and whether the business can run without the founder's direct involvement.

What drives a premium

Majority of revenue from annual subscriptions that renew without active sales effort

Customers deeply embedded in the platform with high switching costs due to revalidation requirements

Multi-year customer retention with documented tenure history across the customer base

Compliance records including FDA documentation and validation certifications organized and current

SBA Loan Calculator

See what your monthly payments would look like at different deal sizes

FAQ

Pharmaceuticals & Biotech Business Acquisition

What should I look for when buying a pharmaceuticals or biotech business?

Start with the revenue model. Businesses where most revenue comes from subscriptions that renew automatically are fundamentally more predictable than those dependent on new customer acquisition. Then understand customer switching costs. In regulated industries, embedded compliance and traceability tools are very hard to replace, which keeps customers in place. Browse pharmaceuticals and biotech businesses for sale on Rejigg to see what's currently available.

How much does a pharmaceuticals or biotech business cost?

Most pharma and biotech businesses sell for 3 to 12 times annual profit, with the wide range reflecting the significant difference between founder-dependent services businesses and highly recurring software platforms with strong customer retention. Use the SBA loan calculator to model your financing options and required equity.

How do I evaluate a pharmaceuticals or biotech business before buying?

Ask for a breakdown of recurring versus non-recurring revenue. Get customer tenure data and understand the concentration of your top five customers. Review compliance documentation including FDA records and validation certificates. Understand whether any key technical or regulatory knowledge is concentrated in the founder, and ask how the team is structured to handle customer relationships independently.

What due diligence questions should I ask about a pharmaceuticals or biotech business?

Ask what percentage of revenue comes from subscriptions that renew without active sales effort. Find out how long each of the top customers has been active and whether any have contracted for multi-year terms. Ask to see FDA documentation and validation records. Understand the technical architecture and whether switching away from the platform requires revalidation. Ask about the founder's involvement in customer relationships and the transition plan.

Where can I find pharmaceuticals and biotech businesses for sale?

Rejigg connects buyers with owners of pharma software companies, biotech services businesses, compliance platforms, and other regulated life sciences companies. You can browse pharmaceuticals and biotech businesses for sale on Rejigg and connect with owners directly.

How does regulation affect the value of a pharma or biotech business?

Regulation is actually a positive factor when it comes to customer retention. Compliance and traceability requirements create steady demand for products and services that help manufacturers meet those requirements. Once a company is set up and validated on a system, switching to a competitor involves a costly revalidation process. That dynamic creates durable customer loyalty that buyers find genuinely valuable.

What if the founder is deeply involved in customer relationships?

Founder-dependent customer relationships are one of the most common risk factors in this space and worth understanding clearly. Ask whether the technical team and account managers have their own direct relationships with customers, and how long those have been in place. A thoughtful transition plan where the seller stays involved for a defined period can bridge this gap effectively, but you want to understand the landscape before you close.